Filter Results:
(6,842)
Show Results For
- All HBS Web
(6,842)
- People (25)
- News (2,084)
- Research (2,626)
- Events (37)
- Multimedia (159)
- Faculty Publications (1,443)
Show Results For
- All HBS Web
(6,842)
- People (25)
- News (2,084)
- Research (2,626)
- Events (37)
- Multimedia (159)
- Faculty Publications (1,443)
- 2023
- Book
Right Kind of Wrong: The Science of Failing Well
By: Amy Edmondson
A revolutionary guide that will transform your relationship with failure, from the pioneering researcher of psychological safety and award-winning Harvard Business School professor Amy Edmondson.
We used to think of failure as the opposite of success. Now,... View Details
We used to think of failure as the opposite of success. Now,... View Details
Edmondson, Amy. Right Kind of Wrong: The Science of Failing Well. New York, NY: Atria Books, 2023.
- February 2008 (Revised August 2008)
- Case
EXACT Sciences Corp.: Commercializing a Diagnostic Test
This case addresses the challenges of commercializing molecular diagnostics. Along the way, it explains the technology, payment system, and the measures used to assess the value of a diagnostic test. View Details
Keywords: Health Testing and Trials; Genetics; Science-Based Business; Commercialization; Biotechnology Industry
Herzlinger, Regina E. "EXACT Sciences Corp.: Commercializing a Diagnostic Test." Harvard Business School Case 308-090, February 2008. (Revised August 2008.)
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
- 29 Jun 2022
- Blog Post
Harvard Business School Announces the 2022-2023 Blavatnik Fellows
Harvard Business School (HBS) has named its 2022-23 Blavatnik Fellows and the program’s ninth cohort. Launched in 2013, the Blavatnik Fellowship in Life Science... View Details
- 05 Oct 2022
- News
Harvard Business School Announces 2022-2023 Kaplan Fellows
- 07 Apr 2023
- News
Honoring the Life and Legacy of Dean Jay O. Light
- 04 Feb 2002
- Research & Ideas
How a Juicy Brand Came Back to Life
Rush Limbaugh. Stern was an especially effective spokesperson. He got to know the founders of the business personally and conveyed to his listeners a genuine and infectious regard for the products and the people behind them. The brand's... View Details
- 08 Jul 2024
- Research & Ideas
The Critical Computer Science Principles Every Strategic Leader Needs to Know
In an AI-world, leaders who speak technology’s language gain an edge. But that doesn’t mean every manager needs a computer science degree. A handle on a handful of basics goes a long way toward preparing strategic leaders for today’s... View Details
- 13 Jun 2017
- Blog Post
MS/MBA: Engineering Sciences – A Q&A with Professor Robert Howe
The first MS/MBA: Engineering Sciences cohort will enroll in the MS/MBA program in August of 2018.The program is a major collaboration between HBS and the Harvard John A. Paulson School of Engineering and Applied View Details
- 01 Mar 2003
- News
Inside the Revolution
academic institution for shaping ideas about management and enterprise in the field of life sciences. “What was needed,” he says, “was an initiative to pull things together and examine the business and... View Details
- 19 Dec 2022
Life at HBS Chat in Monterrey
Join current HBS student, Cecilia Galvan, to hear more about life as an MBA student at Harvard Business School. Come ready with your questions! View Details
- 19 Oct 2015
- Research & Ideas
Business Research that Makes for Smarter Public Policy
to fill little gaps in the literature, and I continue to think that was excellent advice.” Just as researchers in the life sciences often target their work to tackle the most dangerous diseases, so argues... View Details
Keywords: by Michael Blanding
- 26 Sep 2019
- News
Kill science funding and you kill the future tech economy
- September 2019
- Case
Funding Sources for Science & Technology Start-ups in India
By: Tarun Khanna, Arjun Swarup and Rachna Tahilyani
India's start-up ecosystem is amongst the largest globally, with a variety of funding options from angel investors, venture capital and corporate venture capital to debt. Classic consumer focused start-ups which look to leverage technology have been able to raise... View Details
Keywords: Venture Capital; Business Startups; Science; Information Technology; Financial Services Industry; Banking Industry; Technology Industry; India; South Asia
Khanna, Tarun, Arjun Swarup, and Rachna Tahilyani. "Funding Sources for Science & Technology Start-ups in India." Harvard Business School Case 720-401, September 2019.
- March 2022
- Case
Shanghai Pudong Science and Technology Investment Co., Ltd.: December 2014
By: Josh Lerner, Luyang Zhang, Xinlai Tong and Yue Kong
In early December 2014, the senior team of Pudong Science and Technology Investment (hereafter, Pudong S&T) gathered in the offices of their chairman, Dr. Xudong Zhu. Before completing its cross-border acquisition of Montage Technology, Pudong S&T—wholly owned by the... View Details
Lerner, Josh, Luyang Zhang, Xinlai Tong, and Yue Kong. "Shanghai Pudong Science and Technology Investment Co., Ltd.: December 2014 ." Harvard Business School Case 822-111, March 2022.
- Awards
American Political Science Association. Public Policy Section. Best Paper on Public Policy Award
Winner of the 2024 Best Paper on Public Policy Award from the Public Policy Section of the American Political Science Association for “Fighting the Future: Short-Term Investors and Business Opposition to Climate Policy” with Jared Finnegan. View Details
- 30 Sep 2014
- News
Life Lessons on the Open Seas
“Ninety-one percent of the people who go through our program say they have an easier time in their life conquering life’s other challenges,” he says. Callahan was 41 when he took over Sail to Prevail in 1997—only a few years after he’d... View Details
Keywords: Jill Radsken
- May 2018 (Revised June 2018)
- Case
Ashar Group: Brokers and Co-opetition in the Life Settlement Industry
By: Alexander Braun, Lauren H. Cohen, Christopher J. Malloy and Jiahua Xu
Connecting life insurance policyholders with potential investors (called Life Settlement Providers), Ashar Group plays a pivotal role in the industry. Its current position is, however, increasingly being challenged by consumer-direct models, led by major providers... View Details
Keywords: Insurance; Investment; Markets; Competitive Strategy; Cooperation; Financial Services Industry
Braun, Alexander, Lauren H. Cohen, Christopher J. Malloy, and Jiahua Xu. "Ashar Group: Brokers and Co-opetition in the Life Settlement Industry." Harvard Business School Case 218-109, May 2018. (Revised June 2018.)
First Impressions: The Science of Meeting People
A strong handshake and assertive greeting may not be the best way to make a good first impression. New research suggests that people respond more positively to someone who comes across as trustworthy rather than confident.
Social psychologist Amy... View Details- 04 May 2023
Life at HBS Chat in Seoul
Join us for an in-person informal chat about the Harvard Business School MBA Program. This Life at HBS Chat is designed for prospective applicants to learn more about the MBA Program and View Details